D.C. hosts biggest dermatology event of the year


New live demo suture technique sessions were among the many innovative offerings at the 74th Annual Meeting in Washington, D.C.

This year’s 74th Annual Meeting brought dermatologists from across the U.S. — and the world — to Washington, D.C., to experience the biggest dermatology event of the year, packed with fascinating scientific sessions, networking events, and other events.

Attendance numbers in D.C. were impressive, with total attendance exceeding 18,500, including more than 9,800 medical and 1,400 non-medical personnel. International registrants exceeded 4,900. Guest, press, and exhibitor personal reached more than 8,200. Brazil accounted for the highest number of international registrants, at more than 16 percent. Exhibitor personnel numbers were over 6,500.

Did you make The Connection?

The AAD promised a new look in 2016 and delivered in spades. The Connection — located in Hall D of the Walter E. Washington Convention Center — debuted at the meeting. Centralized for attendee efficiency, The Connection included networking lounges, the Plenary session, e-poster exhibits, Poster Presentation Theaters, Standardized Patient Workshops and the AAD Resource Center. It was the ideal location to discover everything the AAD has to offer.

Highlights of the Sunday Plenary

On Sunday March 6, the Plenary took place at The Connection in Hall D, where highly regarded dermatologists gathered to present on a variety of topics, including research methods, drug delivery, advances in genome technology, and a presentation on itch.

Amy S. Paller, MD, gave the Clarence S. Livingood, MD Memorial Award Lecture “Bedside to Bench and Back to the Bedside.” The Eugene J. Van Scott Award for Innovative Therapy of the Skin and Phillip Frost Leadership Lecture, “Tumescent Drug Delivery: Lidocaine and Beyond” was delivered by Jeffrey A. Klein, MD. The Lila and Murray Gruber Memorial Cancer Research Award and Lectureship was presented by Paul A. Khavari, MD, PhD on “Pathogenesis of Skin Cancer.” Gil Yosipovitch, MD, presented the Marion B. Sulzberger, MD, Memorial Award and Lectureship “Itch.” In addition, guest speaker Anthony S. Fauci, MD — the director of the National Institute of Allergy and Infectious Diseases (NIAID) — presented an illuminating talk, “Ending the HIV/AIDS Pandemic: An Achievable Goal.”

Academy leadership also addressed Plenary attendees. Mark Lebwohl, MD, gave his final address as president, where he reflected on his time in office.

“We have had a very challenging and a very productive year,” Dr. Lebwohl said, and talked about how the AAD has a common goal with patient support groups. “We all went into medicine to help patients and cure disease, and the patient support organizations have been our most steadfast supporters in achieving those goals. That is why, when I started a year ago, I declared this the ‘The Year of the Patient,’ and those patient support groups have not let us down.”

Abel Torres, MD, JD, president-elect, spoke about his upcoming term as Academy president. “I look forward to working with you all in building that legacy for a better tomorrow for the Academy, for our patients and for you, my colleagues, who care for them,” he said.

Looking ahead to Boston and Orlando

Plans are under way for the AAD’s 2016 Summer Meeting, July 28-31, in Boston. More information about this event will be available in AAD Meeting News in the coming months. The Academy’s 75th Annual Meeting will be held in Orlando, Florida, March 3-7, 2017.

Return to Index